UA108980C2 - APPLICATION OF DONEDARONE FOR THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATIONS - Google Patents

APPLICATION OF DONEDARONE FOR THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATIONS

Info

Publication number
UA108980C2
UA108980C2 UAA201013631A UAA201013631A UA108980C2 UA 108980 C2 UA108980 C2 UA 108980C2 UA A201013631 A UAA201013631 A UA A201013631A UA A201013631 A UAA201013631 A UA A201013631A UA 108980 C2 UA108980 C2 UA 108980C2
Authority
UA
Ukraine
Prior art keywords
dronedarone
prevention
mortality
medicament
preparation
Prior art date
Application number
UAA201013631A
Other languages
English (en)
Ukrainian (uk)
Inventor
Christophe Gaudin
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Priority claimed from PCT/IB2009/005587 external-priority patent/WO2009144550A2/fr
Publication of UA108980C2 publication Critical patent/UA108980C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA201013631A 2008-04-17 2009-04-16 APPLICATION OF DONEDARONE FOR THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATIONS UA108980C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0802127A FR2930148A1 (fr) 2008-04-17 2008-04-17 Utilisation de la dronedarone pour la preparation d'un medicament destine a la prevention de l'hospitalisation cardiovasculaire ou de la mortalite
PCT/IB2009/005587 WO2009144550A2 (fr) 2008-04-17 2009-04-16 Utilisation de dronédarone dans un médicament utilisé pour prévenir un épisode cardiovasculaire menant à l’hospitalisation ou à la mort

Publications (1)

Publication Number Publication Date
UA108980C2 true UA108980C2 (en) 2015-07-10

Family

ID=39940579

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201013631A UA108980C2 (en) 2008-04-17 2009-04-16 APPLICATION OF DONEDARONE FOR THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATIONS

Country Status (2)

Country Link
FR (1) FR2930148A1 (fr)
UA (1) UA108980C2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ588623A (en) * 2008-04-17 2012-11-30 Sanofi Aventis Use of a medicament containing dronedarone with food for preventing cardiovascular hospitalization
FR2930150B1 (fr) * 2008-06-24 2011-01-14 Sanofi Aventis Utilisation de la dronedarone pour la preparation d'un medicament destine a reguler le taux de potassium dans le sang
WO2011158178A1 (fr) * 2010-06-14 2011-12-22 Sanofi Utilisation de dronédarone pour la préparation d'un médicament pour utilisation dans le traitement de patients
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746013B1 (fr) * 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus

Also Published As

Publication number Publication date
FR2930148A1 (fr) 2009-10-23

Similar Documents

Publication Publication Date Title
EA201071204A1 (ru) Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности
JP2015515475A5 (fr)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX339614B (es) Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
JP2013166781A5 (fr)
BR112012016783A2 (pt) "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
UA108980C2 (en) APPLICATION OF DONEDARONE FOR THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATIONS
WO2007145863A3 (fr) Formulation à libération prolongée de naltréxone
MX363389B (es) Composicion farmaceutica que comprende ivabradina amorfa.
WO2007133796A3 (fr) Procédés et compositions de traitement de l'apnée du sommeil
UA100883C2 (ru) Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
EA201070557A1 (ru) Способы и композиции для замедления набора веса, связанного с применением атипичных антипсихотических препаратов
JP2013032308A5 (fr)
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
MX2010011401A (es) Asociacion de la dronedarona con al menos un diuretico, su aplicacion en terapeutica.
WO2010098625A2 (fr) Préparation pharmaceutique
UA107716C2 (ru) Терапевтическое средство с замедленным высвобождением на основе соединения 2-фенилтиазола для гипертонии и почечной дисфункции
JP2012097034A5 (fr)
JP2016505628A5 (fr)
AR081031A1 (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad en pa-cientes que tienen una primera recurrencia de fibrilacion auricular o ale-teo auricular
Xin et al. Zhengzhou University, Zhengzhou, China
Imai Peripheral neuritis: case report
JP2012072106A5 (fr)
TR201008460A1 (tr) Eslikarbazepinin saşe formülasyonları.
AR080499A1 (es) El uso de dronedarona o una sal farmaceuticamente aceptable de la misma para la preparacion de un medicamento para la administracion poco despues de la interrupcion de amiodarona